Stefan R. Vink

744 total citations
13 papers, 618 citations indexed

About

Stefan R. Vink is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Stefan R. Vink has authored 13 papers receiving a total of 618 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Organic Chemistry and 3 papers in Oncology. Recurrent topics in Stefan R. Vink's work include Cancer therapeutics and mechanisms (7 papers), Cell death mechanisms and regulation (4 papers) and Sphingolipid Metabolism and Signaling (4 papers). Stefan R. Vink is often cited by papers focused on Cancer therapeutics and mechanisms (7 papers), Cell death mechanisms and regulation (4 papers) and Sphingolipid Metabolism and Signaling (4 papers). Stefan R. Vink collaborates with scholars based in Netherlands, Germany and United States. Stefan R. Vink's co-authors include Marcel Verheij, Wim J. van Blitterswijk, Jan H.M. Schellens, Arnold H. van der Luit, Jeffrey Klarenbeek, Wilfried Budach, Verena Jendrossek, Martin Pruschy, Claus Belka and Daniel Perrissoud and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and The FASEB Journal.

In The Last Decade

Stefan R. Vink

13 papers receiving 613 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stefan R. Vink Netherlands	11	485	103	72	65	51	13	618
Alan Bilsland United Kingdom	21	698 1.4×	120 1.2×	67 0.9×	105 1.6×	59 1.2×	37	988
Alexander R. Chait United States	5	305 0.6×	105 1.0×	32 0.4×	38 0.6×	37 0.7×	7	507
Barbara J. Bailey United States	15	370 0.8×	206 2.0×	37 0.5×	47 0.7×	51 1.0×	26	732
Ann Palladino United States	4	352 0.7×	109 1.1×	32 0.4×	55 0.8×	44 0.9×	5	524
Beth Cooper United States	6	504 1.0×	122 1.2×	142 2.0×	68 1.0×	80 1.6×	6	818
Elena Casanova Italy	11	287 0.6×	150 1.5×	39 0.5×	114 1.8×	34 0.7×	23	508
MV Blagosklonny United States	9	547 1.1×	185 1.8×	40 0.6×	66 1.0×	112 2.2×	9	773
Pia Ek Sweden	14	477 1.0×	87 0.8×	25 0.3×	99 1.5×	24 0.5×	28	663
Ida H. van der Meulen‐Muileman Netherlands	14	291 0.6×	110 1.1×	57 0.8×	47 0.7×	33 0.6×	21	460
Sarah K. Madden United Kingdom	9	681 1.4×	108 1.0×	50 0.7×	103 1.6×	41 0.8×	12	806

Countries citing papers authored by Stefan R. Vink

Since Specialization

Citations

This map shows the geographic impact of Stefan R. Vink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan R. Vink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan R. Vink more than expected).

Fields of papers citing papers by Stefan R. Vink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan R. Vink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan R. Vink. The network helps show where Stefan R. Vink may publish in the future.

Co-authorship network of co-authors of Stefan R. Vink

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan R. Vink. A scholar is included among the top collaborators of Stefan R. Vink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan R. Vink. Stefan R. Vink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Lummel, Menno van, Wim J. van Blitterswijk, Stefan R. Vink, et al.. (2010). Enriching lipid nanovesicles with short‐chain glucosylceramide improves doxorubicin delivery and efficacy in solid tumors. The FASEB Journal. 25(1). 280–289. 52 indexed citations

Zerp, Shuraila F., Stefan R. Vink, Pieter Koolwijk, et al.. (2008). Alkylphospholipids inhibit capillary-like endothelial tube formation in vitro: antiangiogenic properties of a new class of antitumor agents. Anti-Cancer Drugs. 19(1). 65–75. 17 indexed citations

Luit, Arnold H. van der, Stefan R. Vink, Jeffrey Klarenbeek, et al.. (2007). A new class of anticancer alkylphospholipids uses lipid rafts as membrane gateways to induce apoptosis in lymphoma cells. Molecular Cancer Therapeutics. 6(8). 2337–2345. 107 indexed citations

Vink, Stefan R., Arnold H. van der Luit, Jeffrey Klarenbeek, Marcel Verheij, & Wim J. van Blitterswijk. (2007). Lipid rafts and metabolic energy differentially determine uptake of anti-cancer alkylphospholipids in lymphoma versus carcinoma cells. Biochemical Pharmacology. 74(10). 1456–1465. 28 indexed citations

Vink, Stefan R., Wim J. van Blitterswijk, Jan H.M. Schellens, & Marcel Verheij. (2007). Rationale and clinical application of alkylphospholipid analogues in combination with radiotherapy. Cancer Treatment Reviews. 33(2). 191–202. 75 indexed citations

Vink, Stefan R., Jan H.M. Schellens, Jos H. Beijnen, et al.. (2006). Phase I and pharmacokinetic study of combined treatment with perifosine and radiation in patients with advanced solid tumours. Radiotherapy and Oncology. 80(2). 207–213. 59 indexed citations

Verbrugge, Inge, Stefan R. Vink, Uta Schaefer, et al.. (2006). TRAIL enhances efficacy of radiotherapy in a p53 mutant, Bcl-2 overexpressing lymphoid malignancy. Radiotherapy and Oncology. 80(2). 214–222. 28 indexed citations

Vink, Stefan R., Elly Mesman, Jan H.M. Schellens, et al.. (2006). Radiosensitization of Squamous Cell Carcinoma by the Alkylphospholipid Perifosine in Cell Culture and Xenografts. Clinical Cancer Research. 12(5). 1615–1622. 48 indexed citations

Veldman, Robert Jan, Gerben A. Koning, Albert J. van Hell, et al.. (2005). Coformulated N-Octanoyl-glucosylceramide Improves Cellular Delivery and Cytotoxicity of Liposomal Doxorubicin. Journal of Pharmacology and Experimental Therapeutics. 315(2). 704–710. 29 indexed citations

10.

Vink, Stefan R., Jan H.M. Schellens, Wim J. van Blitterswijk, & Marcel Verheij. (2005). Tumor and normal tissue pharmacokinetics of perifosine, an oral anti-cancer alkylphospholipid. Investigational New Drugs. 23(4). 279–286. 59 indexed citations

11.

Verheij, Marcel, Stefan R. Vink, Jan H.M. Schellens, et al.. (2004). Phase I study of combined treatment with the oral alkyl-lysophospholipid (ALP) Perifosine and radiation in patients with advanced solid tumors. Journal of Clinical Oncology. 22(14_suppl). 3064–3064. 4 indexed citations

12.

Belka, Claus, Verena Jendrossek, Martin Pruschy, et al.. (2004). Apoptosis-modulating agents in combination with radiotherapy—current status and outlook. International Journal of Radiation Oncology*Biology*Physics. 58(2). 542–554. 110 indexed citations

13.

Verheij, Marcel, Stefan R. Vink, J. H. M. Schellens, et al.. (2004). Phase I study of combined treatment with the oral alkyl-lysophospholipid (ALP) Perifosine and radiation in patients with advanced solid tumors. Journal of Clinical Oncology. 22(14_suppl). 3064–3064. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact